Atlanta, GA, August 23, 2013 --(PR.com
)-- MediPurpose(tm), a master distributor and manufacturer of medical products, today announced an addition to its expanding portfolio of lancet patents.
The medical product company recently received approval of patent EP2303123 ("A Device for Performing an Incision") for its babyLance(tm) safety heelstick from the European Patent Office (EPO) in Berlin, Germany. The patent provides medical device intellectual property protection in the EPO's 38 member states.
Along with medical device patents in Singapore and Japan for babyLance, MediPurpose also holds EPO medical device patents for its popular SurgiLance(tm) safety lancet.
About babyLance Safety Heelsticks
babyLance safety heelsticks are single-use safety needlestick devices for the collection of blood from infants.
After investing more than a year in its redesign, MediPurpose launched the all-new babyLance in August 2012.
babyLance is available in two models, each with a specific blade penetration:
* babyLance BLP (preemie): 0.85 mm depth
* babyLance BLN (newborn): 1.0 mm depth
Specifically designed to meet end-user expectations for the ideal heelstick, the new babyLance provides enhanced stability, comfort and ease of use.
For more information about babyLance safety heelsticks -- including no-cost product sample requests -- please visit http://www.medipurpose.com/babylance .